Yiwen Luo

1PUBLICATIONS
10CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 22, 2024
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.

James Chih-Hsin Yang, Dae Ho Lee, Jong-Seok Lee

Pageof 1

Frequent Collaborators

1 joint publications

James Chih-Hsin Yang

1 joint publications

Dae Ho Lee

1 joint publications

Eiji Iwama

1 joint publications

Takako Inoue

1 joint publications

Jerónimo Rodríguez-Cid

1 joint publications

Cheng-Ta Yang

1 joint publications

Maurice Pérol

1 joint publications

Ki Hyeong Lee

1 joint publications

Gregory J Riely

1 joint publications

Shun Lu

Frequent Collaborators

1 joint publications

James Chih-Hsin Yang

1 joint publications

Dae Ho Lee

1 joint publications

Eiji Iwama

1 joint publications

Takako Inoue

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.9K
See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.9K
See more related videos